Induction of Cyclo-Oxygenase and Nitric Oxide Synthase in Inflammation

Advances in Pharmacology

Volumn 35, Issue C, 1996, Pages 27-77

  Appleton, Ian ^a   Tomlinson, Annette ^a   Willoughby, Derek A ^a  

^a Department of Experimental Pathology ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIC AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

CHEMISTRY; CLASSIFICATION; INFLAMMATION; METABOLISM; PHYSIOLOGY; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACIDS; DINOPROSTONE; INFLAMMATION; NITRIC OXIDE SYNTHASE; OXYTOCICS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0029679854     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60274-4     Document Type: Article

References (329)

1. Abramson S.B., and Weissmann G. The mechanism of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 32 (1989) 1-9
2. Akai Y., Homma T., Burns K.D., Yasuda T., Badr K.F., and Harris R.C. Mechanical stretch/relaxation of cultured rat mesangial cells induces protooncogenes and cyclooxygenase. Am. J. Physiol. 267 (1994) C482-C490
3. Akarasereenont P., Mitchell J.A., Appleton I., Thiemermann C., and Vane J.R. Involvement of protein tyrosine phosphorylation in the induction of cyclooxygenase by endotoxin in endothelial cells and macrophages: A comparison with nitric oxide synthase. Br. J. Pharmacol. 113 4 (1994) 1522-1528
4. Albina J.E., Mills C.D., Henry W.L., and Caldwell M.D. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J. Immunol. 144 (1990) 3877-3880
5. Al-Duaij A.Y., DeBrito F.B., Sedgwick A.D., Scott D.L., and Willoughby D.A. Susceptibility of cartilage to damage by immunological inflammation. Int. Arch. Allergy Appl. Immunol. 80 (1986) 435-437
6. Anggard E. Nitric oxide: Mediator, murderer, and medicine. Lancet 343 (1994) 1199-1206
7. Appleton I. Wound repair: The role of cytokines and vasoactive mediators. J. R. Soc. Med. 87 (1994) 500-502
8. Appleton I., Tomlinson A., Colville-Nash P.R., and Willoughby D.A. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. Lab. Invest. 69 (1993) 405-414
9. Appleton I., Tomlinson A., and Willoughby D.A. Inducible cyclooxygenase (COX-2). A safer therapeutic target. Br. J. Rheumatol 33 (1994) 410-412
10. Appleton I., Tomlinson A., Mitchell J.A., and Willoughby D.A. Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti-inflammatory therapy. J. Pathol. 176 (1995) 413-420
11. Ausprunk D.H., Knighton D.R., and Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic study. Dev. Biol. 38 (1974) 237-248
12. Baenziger N.L., Becherer P.R., and Majerus P.W. Characterisation of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts. Cell 16 (1979) 967-973
13. Bailey J.M., Muzza B., Hla T., and Salata K. Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: Regulation by epidermal growth factor. J. Lipid Res. 26 (1985) 54-61
14. Bastian N.R., Xu S., Shao X.C., Shelby J., Granger D.L., and Hibbs Jr. J.B. N(omega)-monomethyl-L-arginineinhibits nitric oxide production in murine cardiac allo-grafts but does not affect graft rejection. Biochim. Biophys. Acta 1226 (1994) 225-231
15. Battistini B., Botting R., and Bakhle Y.S. COX-1 and COX-2: Toward the development of more selective NSAIDs. Drug News Perspect. 7 (1994) 501-512
16. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1620-1624
17. Bernard C., Merval R., Esposito B., and Tedgui A. Elevated temperature accelerates and amplifies the induction of nitric oxide synthase in rat macrophages. Eur. J. Pharmacol. 270 (1994) 115-118
18. Bernheim H.A., Gilbert T.M., and Sitt J.T. Prostaglandin E levels in third ventricular cerebrospinal fluid of rabbits during fever and changes in body temperature. J. Physiol. 301 (1980) 69-78
19. Betz M., and Fox B.S. Prostaglandin E2 inhibits the production of Thl lymphokines but not Th2 lymphokines. J. Immunol. 146 (1991) 108-113
20. Bienkowski M.J., Petro M.A., and Robinson L.J. Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1 as the second messenger. J. Biol. Chem. 264 (1989) 6536-6544
21. Billiar T.R., Hoffman R.A., Curran R.D., Langrehr J.M., and Simmons R.L. A role for inducible nitric oxide biosynthesis in the liver in inflammation and in the allogeneic immune response. J. Lab. Clin. Med. 120 (1992) 192-197
22. Bockman R.S. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins. J. Clin. Invest. 66 (1980) 523-531
23. Bockman R.S., Hickok N., and Rapuano B. In: Garachi E., Paoletti R., and Santpro M.G. (Eds). "Prostaglandins in Cancer Research" (1987), Springer-Verlag, Berlin. 77-85
24. Bonta I.L., and Parnham M.J.P. Reduced exudation and increased tissue proliferation during chronic inflammation in rats deprived of endogenous prostaglandin precursors. Prostaglandins 14 (1977) 295-307
25. Bonventre J.V. Phospholipase A2 and signal transduction. J. Am. Soc. Nephrol. 3 (1992) 128-150
26. Borgeat P., and Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes: Unstable intermediate in the formation of dihydroxy acids. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 3213-3217
27. Boughton-Smith N.K., Deakin A.M., and Whittle B.J. Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. Agents Actions (1992) C3-C9
28. Boughton-Smith N.K., Evans S.M., Hawkey C.J., Cole A.T., Balsitis M., Whittle B.J., and Moncada S. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 7 (1993) 338-340
29. Boughton-Smith N.K., Evans S.M., Laszlo F., Whittle B.J., and Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol. 110 (1993) 1189-1195
30. Bredt D.S., and Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 682-685
31. Brookes S.J. Neuronal nitric oxide in the gut. J. Gastroenterol Hepatol. 8 (1993) 590-603
32. Brune K., Beck W.S., Geisslinger G., Menzel-Soglowek S., Peskar B.M., and Peskar B.A. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 47 (1991) 257-261
33. Brune K., Menzel-Soglowek S., and Zeilhofer H.U. New evidence for an additional (central) site of action of antipyretic analgesics. In: Jurna I., and Yaksh T.L. (Eds). "Progress in Pharmacology and Clinical Pharmacology Central mechanisms for Analgesia by Acetylsalysilic Acid and Functionally Related Compounds" 110 (1993), Gustav Fischer, Stuttgart.
34. Bryant C.E., Tomlinson A., Mitchell J.A., Elliott J., Schmidt H.H.H.W., Thiemermann C., Gross S.S., Willoughby D.A., and Vane J.R. Localisation of inducible isoforms of nitric oxide synthase and cyclooxygenase in rat fallopian tubes. Br. J. Pharmacol. 111 (1993) 100P
35. Burch R.M., Connor J.R., and Axelrod J. Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6306-6309
36. C.C. Chan., R. Gordon., and C. Brideau., I.W. Rodger., C.S. Li., P. Prasit., P. Tagari., D. Ethier., P. Vickers., S. Boyce., N. Rupniak., J. Webb., R. Hill., A.W. Ford-Hutchinson., (1994). In vivo pharmacology of L-745,337: A novel non steroidal antiinflammatory agent (NSAID) with an ulcerogenic sparing effect in rat and monkey stomach. Proc. Xllth Int. Congress Pharmacol. (IUPHAR) Montreal, Canada.
37. Chang J., Gilman S.C., and Lewis A.J. Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: A possible signal for IL-1 action. J. Immunol. 136 (1986) 1283-1287
38. Chang W.C., Murota S.I., Matsuo M., and Tsurufuji S. A new prostaglandin transformed from arachidonic acid in carrageenin-induced granuloma. Biochem. Biophys. Res. Commun. 72 (1976) 1259-1264
39. 2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels. J. Clin. Invest. 74 (1984) 914-919
40. Cher D.J., and Mosmann T.R. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Thl clones. J. Immunol. 138 (1987) 3668-3672
41. Corbett J.A., Kwon G., Turk J., and McDaniel M.L. II-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide. Biochemistry 32 (1993) 13767-13770
42. 2) in murine bone marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206 (1995) 667-673
43. Colville-Nash P.R., El-Ghazaly M., and Willoughby D.A. The use of angiostatic steroids to inhibit cartilage destruction, an in vivo model of granuloma mediated cartilage degradation. Agents Actions 38 (1993) 126-134
44. Crofford L.J., Wilder R.L., Ristimaki A.P., Sano H., Remmers E.F., Epps H.R., and Hla T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester and corticosteroids. J. Clin. Invest. 93 (1994) 1095-1101
45. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., and Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93 (1994) 2684-2690
46. Crunkhorn P., and Willis A.L. Interaction between prostaglandins E and F given intradermally in the rat. Br. J. Pharmacol. 41 (1971) 507-512
47. Culcasi M., Lafon-Cazal M., Pietri S., and Bockaert J. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J. Biol. Chem. 269 (1994) 12589-12593
48. Cunha F.Q., Moncada S., and Liew F.Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-T in murine macrophages. Biochem. Biophys. Res. Commun. 182 (1992) 1155-1159
49. Cunha F.Q., Assreuy J., Moncada S., and Liew F.Y. Phagocytosis and induction of nitric oxide in murine macrophages. Immunology 79 (1993) 408-411
50. Cuzzolin L., Covforti A., Donini M., Adami A., DelSoldato P., and Benoni G. Effects of intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats. Pharmacol. Res. 29 (1994) 89-97
51. Davies P., Bailey P.J., Goldenburg M., and Ford-Hutchinson A.W. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 2 (1984) 335-357
52. De Brito F.B., Holmes M.J.G., Carney S.L., and Willoughby D.A. Drug effects on a novel model of connective tissue breakdown. Agents Actions 21 (1987) 287-290
53. Denis M. Human monocytes/macrophages: NO or no NO?. J. Leukoc. Biol. 55 (1994) 628-634
54. Desa F.M., Chander C.L., Howat D.W., Moore A.R., and Willoughby D.A. Indomethacin and cartilage breakdown. J. Pharm. Pharmacol. 40 (1988) 667
55. 2 synthase in the endothelium and smooth muscle of bovine aorta. J. Clin. Invest. 72 (1983) 1882-1888
56. DeWitt D.L., and Smith W.L. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from complementary DNA sequence. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 1412-1416
57. DeWitt D.L., El-Harith E.A., Kraemer S.A., Andrews M.J., Yao E.F., Armstrong R.L., and Smith W.L. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J. Biol. Chem. 265 (1990) 5192-5198
58. DeWitt D.L. Prostaglandin endoperoxidase synthase: Regulation of enzyme expression. Biochim. Biophys. Acta 1083 (1991) 121-134
59. DeWitt D.L., and Meade E.A. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch. Biochem. Biophys. 306 (1993) 94-102
60. Dinerman J.L., Lowenstein C.J., and Snyder S.H. Molecular mechanisms of nitric oxide regulation: Potential relevance to cardiovascular disease. Circ. Res. 73 (1993) 217-222
61. Ding A., Nathan C.F., Graycar J., Derynck R., Stuehr D.J., and Srimal S. Macro-phage deactivation factor and transforming growth factor β1,2, and 3, inhibit induction of macrophage nitric oxide synthase by interferon t. J. Immunol. 145 (1990) 940-944
62. Dingle J.T. Cartilage maintenance in osteoarthritis: Interaction of cytokines, NSAID and prostaglandins in cartilage damage and repair. J. Rheumatol. 18 Suppl (1991) 30-37
63. Dingle J.T. Prostaglandins in human cartilage mechanism. J. Lipid Med. 6 (1993) 303-312
64. Di Rosa M., Giroud J.P., and Willoughby D.A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol. 104 (1971) 15-29
65. Dohi M., Sakata Y., Seki J., Namikawa Y., Fujisaki J., Tanaka A., Takasugi H., Motoyama Y., and Yoshida K. The anti-platelet actions of FR122047, a novel cyclooxygenase inhibitor. Eur. J. Pharmacol. 243 (1993) 179-184
66. rd Interscience World Conference on inflammation, Antirheumatics, analgesics, immunomodulators. p. 262.
67. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
68. Edwards J.C., Sedgwick A.D., and Willoughby D.A. The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system. J Pathol. 134 (1981) 147-156
69. Egan R.W., Paxton J., and Kuel F.A. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J. Biol. Chem. 251 (1976) 7325-7335
70. Even G.E., Xie W., Chipman J.G., Robertson D.L., and Simmons D.L. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: Regulation by dexamethasone, mitogens, and oncogenes. Arch. Biochem. Biophys. 306 (1993) 169-177
71. Farrell A.J., Blake D.R., Palmer R.M.J., and Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. An. Rheumatol. Dis. 51 (1992) 1219-1222
72. 1) on lysosomal enzyme release in serotonin-induced gastric ulceration. Ann. Surg. 177 (1973) 648-654
73. Ferreira S.H. Prostaglandins, aspirin-like drugs and analgesia. Nature (London) 240 (1972) 200-203
74. 2. Prostaglandins 16 (1978) 31-37
75. Flower R.J., and Vane J.R. Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol). Nature (London) 240 (1972) 410
76. Flower R.J., and Vane J.R. Inhibition of prostaglandin biosynthesis. Biochem. Pharmacol. 23 (1974) 1439-1450
77. Fogh K., Hansen E.S., Herlin T., Knudsen V., Henriksen T.B., Ewald H., Bunger C., and Kragballe K. 15-hydroxy-eicosatetraenoic acid (15-HETE) inhibits carrageenan-induced experimental arthritis and reduces synovial fluid leukotriene B4 (LTB4). Prostaglandins 37 (1989) 213-228
78. Fong T.A.T., and Mosmann T.R. The role of interferon-gamma in delayed type hypersensitivity mediated by Th 1 clones. J. Immunol. 143 (1989) 2887-2892
79. Ford-Hutchinson A.W. Modification of the lipoxygenase pathway of arachidonic acid metabolism. Adv. Prostaglandin Thromoxane Leukot. Res. 20 (1990) 161-169
80. Form D.M., and Auerbach R. PGE2 and angiogenesis. Proc. Soc. Exp. Biol. Med. 172 (1983) 214-218
81. Forstermann U., Schmidt H.H.H.W., Pollock J.S., Sheng H., Mitchell J.A., Warner T.D., Nakane M., and Murad F. Isoforms of nitric oxide synthase: Characterisation and purification from different cell types. Biochem. Pharmacol. 42 (1991) 1849-1857
82. Frasier-Scott K., Hatzakis H., Seong D., Jones C.M., and Wu K.K. Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of denovo synthesis of prostaglandin H synthase. J. Clin. Invest. 82 (1988) 1877-1883
83. Fujii E., Irie K., and Muraki T. Nitric oxide (NO) plays a role of increase in vascular permeability induced by bradykinin, substance P and 5-HT but not by platelet activating factor (PAF) and histamine in mouse skin. IUPHAR Xllth Int. Con. of Pharmacol. Montreal P14 (1994) 2.16
84. Funk C.D., Funk L.B., Kennedy A.S., Pong A.S., and FitzGerald G.A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression and gene chromosomal assignment. FASEB J. 5 (1991) 2304-2312
85. Furchgott R.F. "Studies on relaxation in rabbit aorta by sodium nitrite: The basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium relaxing factor is nitric oxide". In: Vanhoutte P.M. (Ed). "Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium" (1988) 401-414
86. Futaki N., Arai I., Hamasaki Y., Takahashi S., Higuchi S., and Otomo S. Selective inhibition of NS-398 on prostanoid production in inflammed tissue in rat carrageenan-air pouch inflammation. J. Pharm. Pharmacol. 45 (1993) 753-755
87. Futaki N., Yoshikawa K., Hamasaka Y., Arai I., Higuchi S., Iizuka H., and Otomo S. NS-398, a novel nonsteroidal anti-inflammatory drug with potent analgesic and anti-pyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24 (1993) 105-110
88. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., and Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47 (1994) 55-59
89. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. 373 (1992) 897-902
90. Garside P., Hutton A.K., Severn A., Liew F.Y., and Mowat A.M. Nitric oxide mediates intestinal pathology in graft versus host disease. Eur. J. Immunol. 22 (1992) 2141-2145
91. Gartner M.H., Shearer J.D., Bereiter D.F., Mills C.D., and Caldwell M.D. Wound fluid amino acid concentrations regulate the effect of epidermal growth factor on fibroblast replication. Surgery 110 (1991) 448-456
92. Gilman S.C., Chang J., Zeigler P.R., Uhl J., and Mochran E. Interleukin-1 activates phospholipase A2 in human synovial cells. Arthritis Rheumatol. 31 (1988) 126-130
93. Glatt M., Peskar B., and Brune K. Leukocytes and prostaglandins in acute inflammation. Experientia 30 (1974) 11257-11259
94. Goldyne M.E., and Stobo J.D. T-cell-derived arachidonic acid and eicosanoid synthesis by macrophages. Adv. Prostaglandin Thromboxane Leukot. Res. 12 (1983) 39-43
95. Goodwin J.S., Messner R.P., and Peake G.T. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. J. Clin. Invest. 62 (1978) 753-760
96. Gorbunov N., and Esposito E. Nitric oxide as a mediator of inflammation. Int. J. Itnmunopathol. Pharmacol. 6 (1993) 67-75
97. Gowan M., Wood D.D., and Russell R.G. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J. Clin. Invest. 75 (1985) 1223-1229
98. Granger D.L., Hibbs J.B., Perfect J.R., and Durack D.T. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85 (1990) 264-273
99. Granstrom E., and Kumlin M. Metabolism of prostaglandins and lipoxygenase products: Relevance for eicosanoid assay. In: Benedetto C., McDonald-Gibson R.G., Nigam S., and Slater T.F. (Eds). "Prostaglandins and Related Substances: A Practical Approach" (1987) 5-27
100. Green L.C., RuizdeLuzuriaga K., Wagner D.A., Rand W., Istfan N., Young V.R., and Tannenbaum S.R. Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 7764-7768
101. Green S.J., Nacy C.A., and Meltzer M.S. Cytokine induced synthesis of nitrogen oxides in macrophages: A protective host response to Leishmania and other intracellular pathogens. J. Leukocyte Biol. 50 (1991) 93-103
102. Grilli M., Chiu J.J.-S., and Lenardo M.J. NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143 (1993) 1-62
103. Griscavage J.M., Rogers N.E., Sherman M.P., and Ignarro L.G. Inducible nitric oxide synthase from rat alveolar cell line is inhibited by nitric oxide. J. Immunol. 151 (1993) 6329-6337
104. Grisham M.B., Ware K., Gilleland Jr. H.E., Gilleland L.B., Abell C.L., and Yamada T.;. Neutrophil mediated nitrosamine formation: A role for nitric oxide in rats. Gastroenterology 103 (1992) 1260-1266
105. Gryglewski R.J., Botting R.M., and Vane J.R. Mediators produced by the endothelial cell. Hypertension 12 (1988) 530-548
106. Habenicht A.J.R., Goerig M., Grulich J., Rothe D., Gronwald R., Loth U., Schettler G., Kommerell B., and Ross R. Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis on cyclooxygenase. J. Clin. Invest. 75 (1985) 1381-1387
107. Habib A., Creminon C., Frobert Y., Grassi J., Pradelles P., and Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J. Biol. Chem. 268 (1993) 23448-23454
108. A. Habib., C. Bernard., and A. Tedgui., J. Maclouf., (1994) Evidence of cross-talks between inducible nitric oxide synthase and cyclooxygenase II in rat peritoneal macrophages. Proc. 9th International Conference on prostaglandins and related compounds. Florence, p. 57.
109. Haeuselmann H.J., Oppliger L., Michel B.A., Stefanovic-Racic M., and Evans C.H. Nitric oxide and proteoglycan synthesis by human articular chondrocytes in alginate culture. FEBS Lett. 352 (1994) 361-364
110. Hamberg M., and Samuelsson B. On the mechanism of the biosynthesis of Prostaglandin El and Flα. J. Biol. Chem. 242 (1967) 5336-5343
111. Hamberg M., Svensson J., and Sammuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 2994-2998
112. 2 production by keratinocytes. Potential role for NO in regulation of wound healing. J. Biol. Chem. 267 (1992) 21277-21280
113. Hefley T.J., Krieger N.S., and Stern P.H. Simultaneous measurement of bone resorption and collagen synthesis in neonatal mouse calvaria. Anal. Biochem. 153 (1986) 166-171
114. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthease. Biochem. J. 281 (1992) 627-630
115. Herlin T., Fogh K., Hansen E.S., Andreasen A., Knudsen V., Henriksen T.B., Bunger C., and Kragballe K. 15-HETE inhibits leukotriene B4 formation and synovial cell proliferation in experimental arthritis. Agents Actions 29 (1990) 52-53
116. Hempel S.L., Monick M.M., and Hunninghake G.W. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J. Clin. Invest. 93 (1994) 391-396
117. Herman A.G., and Moncada S. Release of prostaglandins and incapacitation after injection of endotoxin in the knee joint of dogs. Br. J. Pharmacol. 53 (1975) 465P
118. Herschmann H.R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60 (1991) 281-319
119. H.R. Herschmann, W. Xie., and R.D. Andersen., B.S. Fletcher., S. Reddy., R. Gilbert., (1994) Regulation and function of the inducible prostaglandin synthase TIS10/PGS2. Proc. 9th International Conference on prostaglandins and related compounds, Florence, p. 1.
120. Herrmann F., Lindemann A., Gauss J., and Mertelsmann R. Cytokine-stimulation of prostaglandin synthesis from endogenous and exogenous arachidonic acids in polymor-phonuclear leukocytes involving activation and new synthesis of cyclooxygenase. Eur. J. Immunol. 20 (1990) 1513-1516
121. Hial V., Horakova Z., Shaff F.E., and Beaven M.A. Alteration of tumour growth by aspirin and indomethacin: Studies with two transplanted tumours in mice. Eur. J. Pharmacol. 37 (1976) 367-376
122. Hibbs Jr. J.B., Vavrin Z., and Taintor R.R. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138 (1987) 550-565
123. Hibbs Jr. J.B., Taintor R., Vavrin Z., and Rachlin C. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157 (1988) 87-94
124. Higgs G.A., Moncada S., and Vane J.R. Eicosanoids and inflammation. Ann. Clin. Res. 16 (1984) 287-299
125. Holthusen H., and Arndt J.O. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci. Lett. 165 (1994) 71-74
126. Holtzman M.J., Turk J., and Shornick L.P. Alteration of a novel prostaglandin endoperoxide synthase by aspirin so 15-hydroxyeicosatetraenoic acid and not prostaglandin is the major product. Clin. Res. 39 (1991) 182 [Abstract].
127. Hutcheson I.R., Whittle B.J., and Boughton-Smith N.K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br. J. Pharmacol. 101 (1990) 815-820
128. Ialenti A., Ianaro A., Moncada S., and Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211 (1992) 177-182
129. Ianaro A., Xu D., O'Donnell C.A., DiRosa M., and Liew F.Y. Expression of TGFβ in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and INF-τ, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology 84 (1995) 8-15
130. Ignarro L.J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41 (1991) 485-490
131. Iuvone T., Carnuccio R., and Di Rosa M. Modulation of granuloma formation by endogenous nitric oxide. Eur. J. Pharmacol. 265 (1994) 89-92
132. Iyengar R.D., Steuhr D.J., and Marietta M.A. Macrophage synthesis of nitrite, nitrate and N-nitrosamines: Precursors and role of the respiratory burst. Proc. Natl. head. Sci. U.S.A. 84 (1987) 6369-6373
133. James S.L., and Hibbs Jr. J.B. Therole of nitrogen oxides as effector molecules of parasite killing. Parasitol. Today 6 (1990) 303-309
134. James S.L., and Nacy C. Effector functions of activated macrophages against parasites. Curr. Opin. Immunol. 5 (1993) 518-523
135. Jansen A., Cook T., Taylor G.M., Largen P., Riveros-Moreno V., Moncada S., and Cattell V. Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int. 45 (1994) 1215-1219
136. Johnson K.J., and Ward P.A. Acute immunologic pulmonary alveolitis. J. Clin. Invest. 54 (1979) 349-357
137. Jones D.A., and Fitzpatrick F.A. Thromboxane A2 synthase. Modification during "suicide" inactivation. J. Biol. Chem. 266 (1991) 23510-23518
138. Joulou-Schaeffer G., Gray G.A., Fleming I., Schott C., Parratt J.R., and Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259 (1990) H1038-H1043
139. Juhlin S., and Michaelson G. Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopia dermatitis. Acta Derma. Venereol. 49 (1969) 161-251
140. Katori M., Harada Y., Hatanaka K., Majima M., Kawamura M., Ohno T., Aizawa A., and Yamamoto S. Induction of prostaglandin H synthase-2 in rat carrageenin-induced pleurisy and effect of selective COX-2 inhibition. Adv. Prostaglandin Thromboxtane Leukot. Res. 23 (1995) 345-348
141. Keller R., Keist R., Joller P., and Groscurth P. Mononuclear phagocytes from bone marrow progenitor cells, morphology, surface phenotype, and functional properties of resting and activated cells. Clin. Exp. Immunol. 91 (1993) 176-182
142. Kent R.S., Diedrich S.L., and Whorton A.R. Regulation of vascular prostaglandin synthesis by metabolites of arachidonic acid in perfused rabbit aorta. J. Clin. Invest. 72 (1983) 455-465
143. Kester M., Coroneos E., Thomas P.J., and Dunn M.J. Endothelin stimulates prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis through a tyrosine kinase-signaling pathway in rat mesangial cells. J. Biol. Chem. 269 36 (1994) 22574-22580
144. Khalil Z., and Helme R.D. The qualitative contribution of nitric oxide and sensory nerves to bradykinin-induced inflammation in rat skin microvasculature. Brain Res. 589 (1992) 102-108
145. Klein D.C., and Raisz L.G. Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology 86 (1970) 1436-1440
146. Koehler L., Hass R., Wessel K., DeWitt D.L., Kaever V., Resch K., and Goppelt-Streube M. Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U937. Biochim. Biophys. Acta 1042 (1990) 395-403
147. Kolb Kolb-Bachofen H. Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia 35 (1992) 796-801
148. Kopp E., and Ghosh S. Inhibition of NF-KB by sodium salicylate and aspirin. Science 265 (1994) 956-959
149. Koshland D.E. The molecular of the year (Editorial). Science 258 (1992) 1861
150. Kubes P., Suzuki M., and Granger D.M. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4651-4655
151. Kubes P. Polymorphonuclear leukocyte-endothelium interactions: A role for pro-inflammatory and anti-inflammatory molecules. Can. J. Physiol. Pharmacol. 71 (1992) 88-97
152. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., and Herschman H.R. TIS10, a phrobol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266 (1991) 12866-12872
153. Kunkel S.L., Chensue S.W., and Phan S.H. Prostaglandins as endogenous mediators of interleukin 1 production. J. Immunol. 136 (1986) 186-192
154. Kunkel S.L., Wiggins R.C., Chensue S.W., and Larrick J. Regulation of macrophage tumour necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun. 137 (1986) 404-410
155. Kuo H.P., Liu S., and Barnes P.J. The effect of endogenous nitric oxide onneurogenic plasma exudation in guinea pig airways. Eur. J. Pharmacol. 221 (1992) 385-388
156. Lancaster Jr. J.R., Langrehr J.M., Bergonia H.A., Mirase N., Simmons R.L., and Hoffman R.A. EPR detection of heme and non heme iron containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J. Biol. Chem. 267 (1992) 10994-10998
157. Langrehr J.M., Muller A.R., Bergonia H.A., Jacob T.D., Lee T.K., Schraut W.H., Lancaster Jr. J.R., Hoffman R.A., and Simmons R.L. Detection of nitric oxide by electron paramagnetic resonance spectroscopy during rejection and graft versus disease after small bowel transplantation in the rat. Surgery 112 (1992) 395-401
158. Langrehr J.M., White D.A., Hoffman R.A., and Simmons R.L. Macrophages produce nitric oxide at allograft sites. Ann. Surg. 218 (1993) 159-166
159. Laskin J.D., Heck D.E., and Laskin D.L. Multifunctional role of nitric oxide in inflammation. Trends Endocrinol. Metab. 5 (1994) 377-382
160. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., and Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267 (1992) 25934-25938
161. 2 on gastric secretion and experimental peptic ulcerations. Prostaglandins 3 (1973) 29-45
162. Lehn M., Weiser W.Y., Engelhorn S., Gillis S., and Remold H.G. IL-4 inhibits H202 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. J. Immunol. 143 (1989) 3020-3024
163. 2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129 4 (1982) 1627-1631
164. Liew F.Y., Millott S., Li Y., Lelchuk R., Chan W.L., and Ziltener H. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL) 3 and IL4 production by disease-promoting T cells in leishmaniasis. Eur. J. Immunol. 19 (1989) 1227-1232
165. Liew F.Y., Li Y., Severn A., Millott S., Schmidt A., Salter M., and Moncada S. A possible novel pathway of regulation by murine T helper-2 (Th2) cells of a Thl cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21 (1991) 2489-2494
166. Lin R.F., Lin T.S., Tilton R.G., and Cross A.H. Nitric oxide localised to the spinal cords of mice with an experimental allergic encephalomyelitis: An electron paramagnetic resonance study. J. Exp. Med. 178 (1993) 643-648
167. Lippe I.T., Stabentheiner A., and Holzer P. Role of nitric oxide in the vasodilator but not exudative components of mustard oil-induced inflammation in rat skin. Agents Action 38 (1993) C22-C24
168. Lowenstein C.J., Dinerman J.L., and Snyder S.H. Nitric oxide: A physiologic messenger. Ann. Intern. Med. 120 (1994) 227-237
169. Maclntyre D.E., Pearson J.D., and Gordon J.L. Localisation and stimulation of prostacyclin production in vascular cells. Nature (London) 271 (1978) 549-551
170. MacKendrick W., Caplan M., and Hsueh W. Endogenous nitric oxide protects against platelet activating factor-induced bowel injury in the rat. Pediatr. Res. 34 (1993) 222-228
171. MacNaughton W.K., Cirino G., and Wallace J.L. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 45 (1989) 1869-1876
172. Malawista S.E., Montgomery R.R., and van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes. J. Clin. Invest. 90 (1992) 631-635
173. Marcus A.J., Weksler B.B., Jaffe E.A., and Broekman M.J. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured endothelial cells. J. Clin. Invest. 66 (1980) 979-986
174. Marietta M.A., Poksyn S.Y., Iyengar R., Leaf C.D., and Wishnok J.S. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry 27 (1988) 8706-8711
175. Marietta M.A. Nitric oxide synthase structure and mechanism. J. Biol. Chetn. 268 (1994) 12231-12234
176. Marotta P., Sautebin L., and DiRosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107 (1992) 640-641
177. Martin J.H., and Edwards S.W. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumour killing. J. Immunol. 150 (1993) 3478-3486
178. Masferrer J.L., Seibert K., Zweifel B., and Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3917-3921
179. Masferrer J.L., Zweifel B.S., Manning P.T., Hauser S.D., Leahy K.M., Smith W.G., Isakson P.C., and Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3228-3232
180. Mayer B., John M., Heinzel B., Werner E.R., Wachter H., Schiltz G., and Bohme E. Brain nitric oxide synthase is a biopterin- and flavin-containing multifunctional oxido-reductase. FEBS Lett. 288 (1991) 187-191
181. McCall T., Boughton-Smith N.K., Palmer R.M.J., Whittle B.J.R., and Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem. J. 261 (1989) 293-296
182. McCall T., Feelisch M., Palmer R.M.J., and Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br. J. Pharmacol. 102 (1991) 234-238
183. McCall T., and Vallance P. Nitric oxide takes centre stage with newly denned roles. Trends Pharmacol. Sci. 13 (1992) 1-6
184. McCartney-Francis N., Allen J.B., Mizel D.E., Albina J.E., Xie Q.W., Nathan C.F., and Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178 (1993) 749-754
185. McConalogue K., and Furness J.B. Gastrointestinal neurotransmitters. Baillieres. Clin. Endocrinol. Metab. 8 (1994) 51-76
186. McCormack K., and Brune K. Dissociation between the anti-nociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: A survey of their analgesic efficacy. Drugs 41 (1991) 533-547
187. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 59 (1994) 9-43
188. Meerpohl H.G., and Bauknecht T. Role of prostaglandins in the regulation of macrophage proliferation and cytotoxic functions. Prostaglandins 31 (1986) 961-972
189. Mertz P.M., DeWitt D.L., Stetler-Stevenson W.G., and Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J. Biol. Chem. 269 33 (1994) 21322-21329
190. Middleton S.J., Shorthouse M., and Hunter J.O. Relaxation of distal colonic circular smooth muscle by nitric oxide derived from human leucocytes. Gut 34 (1993) 814-817
191. Miller M.J., Chotinaruemol S., Sadowska-Krowicka H., Kakkis J.L., Munshi U.K., Zhang X.J., and Clark D.A. Nitric oxide: the "Jekyll and Hyde" of gut inflammation. Agents Actions 39 (1993) C180-C182
192. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., and Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and indueible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11693-11697
193. Miyamoto T., Ogino N., Yamamoto S., and Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 251 (1976) 2629-2636
194. Miyata A., Hara S., Yokoyama C., Inoue H., Ullrich V., and Tanabe T. Molecular cloning and expression of prostacyclin synthase. Biochem. Biophys. Res. Commun. 200 (1994) 1728-1734
195. Mizuno K., Yamamoto S., and Lands W.E.M. Effects of non-steroidal anti-inflammatory drugs on fatty acid cyclooxygenase and prostaglandin hydroperoxidase activities. Prostaglandins 23 (1982) 743-757
196. Moncada S., Ferreira S.H., and Vane J.R. Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur. J. Pharmacol. 31 (1975) 250-260
197. Moncada S., Gryglewski R.J., Bunting S., and Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263 (1976) 663-665
198. Moncada S., Palmer R.M.J., and Higgs E.A. Biosynthesis of nitric oxide from 1-arginine: A pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38 (1989) 1709-1715
199. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
200. Monick M., Glazier J., and Hunninghake G.W. Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2. Am. Rev. Respir. Dis. 135 (1987) 72-77
201. Moore A.R., Willis D., Gilroy D.W., Tomlinson A., Appleton I., and Willoughby D.A. Cyclooxygenase in rat pleural hypersensitivity reactions. Adv. Prostaglandin Thromboxane Leukot. Res. 23 (1995) 349-351
202. Morley J., Bray M.A., Jones R.W., Nugteren D.H., and Van Dorp D.A. Prostaglandin and thromboxane production by human and guinea-pig macrophages and leukocytes. Prostaglandins 17 (1979) 730-736
203. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989) 145-173
204. Mulligan M.S., Warren J.S., Smith C.W., Anderson D.C., Yeh C.G., Rudolph A.R., and Ward P.A. Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginine. J. Immunol. 148 (1992) 3086-3092
205. Nakazato Y., Simonson M.S., Herman W.H., Konieczowski M., and Sedor J.R. Interleukin-1 alpha stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a nonpancreatic (type II) phospholipase A2. J. Biol. Chem. 266 (1991) 119-127
206. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6 (1992) 3051-3064
207. Nathan C., and Hibbs Jr. J.B. Roleof nitric oxide synthesis in macrophage antimicrobial activity. Curt. Opin. Immunol. 3 (1991) 65-70
208. Nathan C., and Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269 (1994) 13725-13728
209. Nathan C., and Xie Q.W. Nitric oxide synthases: Roles, tolls, and controls. Cell 78 (1994) 915-918
210. Naworth P.P., Stern D.M., Kaplan K.L., and Nossel H.L. Prostacyclin production by perturbed bovine aortic endothelial cells in culture. Blood 64 (1984) 801-806
211. Naxaki T., Nakayama M., and Kato R. Inhibition of nitric oxide and nitric oxide producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. 189 (1990) 347-353
212. Nussler A.K., and Billiar T.R. Inflammation immunoregulation and inducible nitric oxide. J. Leuko. Biol. 54 (1993) 171-178
213. M.K. O'Banion., J.C. Dusel., and J.W. Chang., P.D. Coleman., (1994) Cytokine induction of prostaglandin G/H synthase-2 (PGHS-2) and inducible nitric oxide synthase (iNOS) in primary murine glial cell cultures. Proc. 9th International Conference on prostaglandins and related compounds, Florence p. 113.
214. Ogino N., Miyamoto T., Yamamoto S., and Hayaishi O. Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. J. Biol. Chem. 252 (1977) 890-895
215. Ohshima H., and Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogensis. Mutation Res. 305 (1994) 253-264
216. O'Neill G.P., and Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330 (1993) 156-160
217. O'Neill L.A., Barrett M.L., and Lewis G.P. Induction of cyclooxygenase by interleukin-1 in rheumatoid synovial cells. FEBS Lett. 212 (1987) 35-39
218. O'Sullivan M.G., Huggins E.M., Meade E.A., DeWitt D.L., and McCall C.E. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Bio-chem. Biophys. Res. Commun. 187 (1992) 1123-1127
219. Owens M.W., and Grisham M.B. Nitric oxide synthesis by rat pleural mesothelial cells: Induction by cytokines and lipopolysaccharide. Am. J. Physiol. 265 (1993) L110-L116
220. Padgett E.L., and Pruett S.B. Rat, mouse and human neutrophils stimulated by a variety of activating agents produce much less nitrite than rodent macrophages. Immunology 84 (1995) 135-141
221. Pagels W.R., Sachs R.J., Marnett L.J., DeWitt D.L., Day J.S., and Smith W.L. Immunochemical evidence for the involvement of prostaglandin endoperoxidase synthase in hydroperoxide-dependent oxidations by ram seminal vesicles. J. Biol. Chem 258 (1983) 6517-6525
222. Palmer R.M.J., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
223. Parker C.W. Leukotrienes and prostaglandins in the immune system. Adv. Prostaglandin Thromboxane Leuko. Res. 16 (1986) 113-134
224. Parks D.J., Cheung M.K., Chan C.C., and Roberge F.G. The role of nitric oxide in uveitis. Arch. Opthalmol. 112 (1994) 544-546
225. Partridge N.C., Jeffrey J.J., Ehlich L.S., Teitelbaum S.L., Fliszar C., Welgus H.G., and Kahn A.J. Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells. Endocrinology 120 (1987) 1956-1963
226. Peterson H.I. Tumour angiogenesis inhibition by prostaglandin synthetase inhibitors. Anticancer Res. 6 (1986) 251-253
227. Peterson D.A., Peterson D.C., Archer S., and Weir E.K. The non specificity of specific nitric oxide synthase inhibitors. Biochem. Biophys. Res. Commun. 187 2 (1992) 797-801
228. Phipps R.P., Roper R.L., and Stein S.H. Regulation of B-cell tolerance and triggering by macrophages and lymphoid dendritic cells. Immunol. Rev. 117 (1990) 135-158
229. Phipps R.P., Stein S.H., and Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12 10 (1991) 349-352
230. 2 synthase-1. Nature (London) 367 (1994) 243-249
231. Pipili-Synetos E., Sakkoula E., Haralabopoulos G., Paraskevi A., Persteris P., and Maragoudakis M.E. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111 (1994) 894-902
232. Pou S., Surichamorn W., Bredt D.S., Snyder S.H., and Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267 (1992) 24173-24176
233. Quadt J.F.A., Voss R., and Ten-Hoor F. Prostacyclin production of the isolated pulsatingly perfused rat aorta. J. Pharmacol. Methods 7 (1982) 263-270
234. Radi R., Beckman J.S., Bush K.M., and Freeman B.A. Peroxynitrite oxidation of sulfhydryls: The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266 (1991) 4244-4250
235. Radomski M.W., Palmer R.M., and Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92 (1987) 181-187
236. Radomski M.W., Palmer R.M.J., and Moncada S. The anti-aggregatory properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92 (1987) 639-646
237. Radomski M.W., Palmer R.M., and Moncada S. Endogenous nitric oxide inhibits platelet adhesion to vascular endothelium. Lancet 2 (1987) 1057-1058
238. Radomski M.W., Palmer R.M., and Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148 (1987) 1482-1489
239. Radomski M.W., Palmer R.M.J., and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 10043-10047
240. Raij L., and Schultz P.J. Endothelium-derived relaxing factor, nitric oxide: Effects on and production by mesangial cells and the glomerulus (editorial). J. Am. Soc. Nephrol. 3 (1993) 1435-1441
241. Raz A., Wyche A., and Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1657-1661
242. Raz A., Wyche A., Jiyi F., Sibert K., and Needleman P. Regulation of prostanoid synthesis in human fibroblasts and human blood monocytes by interleukin-1, endotoxin and glucocorticoids. In: Smuelsson B., et al. (Ed). "Advances in Prostaglandin, Thromboxane and Leukotriene Research" 20 (1990), Raven Press, New York. 22-27
243. Rees D.D., Palmer R.M.J., Schulz R., Hodson H.F., and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101 (1990) 746-752
244. Reuter B.K., Cirino G., and Wallace J.L. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci. 55 (1994) PL1-PL8
245. Rimarachin J.A., Jacobson J.A., Szabo P., Maclouf J., Creminon C., and Weksler B.B. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler. Thromb. 14 (1994) 1021-1031
246. Robinson D.R., Smith H., McGuire M.B., and Levine L. Prostaglandin synthesis by rheumatoid synovium and its stimulation by colchicine. Prostaglandins 10 (1975) 67-85
247. Rossi V., Breviario F., Ghezzi P., Dejana E., and Mantovani A. Prostacyclin synthesis induced in vascular cells by interleukin-1. Science 229 (1985) 174-176
248. Ryseck R., Raynoschek C., Macdonald-Bravo H., Dorfman K., and Bravo R. Identification of an immediate early gene, PGHS-b, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth Differ. 3 (1992) 443-450
249. Salmon J.A., Higgs G.A., Vane J.R., Bitensky L., Chayen J., Henderson B., and Cahman B. Synthesis of arachidonic cyclo-oxygenase products by rheumatoid and non-rheumatoid synovial lining in nonproliferative organ culture. Ann. Rheum. Dis. 42 (1983) 36-39
250. Salvemini D., de Nucci G., Gryglewski R.J., and Vane J.R. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 6328-6332
251. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzyme. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7240-7244
252. Salvemini D., Seibert K., Masferrer J.L., Misko T.P., Currie M.G., and Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93 (1994) 1940-1947
253. Sanders K.M., and Ward S.M. Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am. J. Physiol. 262 (1992) G379-G392
254. L. Sautebin., M. Di Rosa., (1994) Nitric oxide regulates PGI2 production by lungs from LPS-treated rats. Proc. 9th International Conference on prostaglandins and related compounds, Florence, p. 57.
255. Schultz P.J., Tayeh M.A., Marietta M.A., and Raij L. Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am. J. Physiol. 261 (1991) F600-F606
256. Schultz R.M., Stoychkov J.N., Pavlidis N., Chirigos M.A., and Olkowski Z.L. Role of E-type prostaglandin in the regulation of interferon-treated macrophage cytotoxic activity. J. Reticuloendothel. Soc. 26 (1979) 93-100
257. 4. FEBS Lett. 244 (1989) 357-360
258. Schmidt H.H.H.W., and Walter U. NO at work. Cell 78 (1994) 919-925
259. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L.N., and Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12013-12017
260. Shen R.-F., Baek S.J., Lee K.-D., Zhang L., and Fleischer T. Genomic organization and regulation of the human thromboxane synthase gene. Adv. Prostaglandin Thromboxone Leukot. Res. 23 (1995) 137-139
261. Siess W. Molecular mechanisms of platelet activation. Physiol. Rev. 69 (1989) 58-178
262. Sigal E. The molecular biology of mammalian arachidonic acid metabolism. Am. J. Physiol. 260 (1991) L13-L28
263. Simmons D.L., Xie W., Chipman J.G., and Evett G.E. Multiple cyclooxygenases: Cloning of a mitogen-inducible form. In: Bailey J.M. (Ed). "Prostaglandins, Leukotrienes, Lipoxins and PAF" (1991) 67-78
264. Sirios J., and Richards J.S. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in rat preovulatory follicles. J. Biol. Chem. 267 (1992) 6382-6388
265. Smith W.L., Marnett L.J., and DeWitt D.L. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther. 49 (1991) 153-179
266. W.L. Smith., M.K. Regier., I. Morita., M. Schindler., D.L. DeWitt. Laneuville., M. Lecomte., D. Bhattacharyya., J.C. Otto., (1994). Structure, function and regulation of PGH synthase isozymes. Proc. 9th International Conference on prostaglandins and related compounds, Florence, p. 2.
267. Snyder S.H., and Bredt D. Biological roles of nitric oxide. Sci. Am. 266 (1992) 28-35
268. Spisni E., Manica F., and Tomasi V. Involvement of prostanoids in the regulation of angiogenesis by polypeptide growth factors. Prostaglandins Leukot. Essent. Fatty Acids 47 (1992) 111-115
269. Stamler J.S. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78 (1994) 931-936
270. Steel J.H., Terenghi G., Chung J.M., Na H.S., Carlton S.M., and Pollack J.M. Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglion in a neuropathic pain model. Neurosci. Lett. 169 (1994) 81-84
271. Stefanovic-Racic M., Stadler J., and Evans C.H. Nitric oxide and arthritis. Arthritis Rheum. 36 (1993) 1036-1044
272. Stuehr D.J., and Marietta M.A. Nitrate biosynthesis: Mouse macrophages produce nitrate and nitrite in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 7738-7742
273. Stuehr D.J., and Marietta M.A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon τ. J. Immunol. 139 (1987) 518-525
274. Steuhr D.J., Gross S.S., Sakuma I., Levi R., and Nathan C.F. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169 (1989) 1011-1020
275. Stuehr D.J., and Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J. Exp. Med. 169 (1989) 1543-1555
276. Sumitani K., Kawata T., Yoshimoto T., Yamamoto S., and Kumegawa M. Fatty acid cyclooxygenase activity stimulated by transforming growth factor-beta in mouse osteoblastic cells (MC3T3-E1). Arch. Biochem. Biophys. 270 (1989) 588-595
277. Swierkosz T.A., Mitchell J.A., Warner T.D., Boning R.M., and Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase: Interactions between nitric oxide and prostanoids. Br. J. Pharmacol. 114 (1995) 1335-1342
278. Sykes J., and Maddox J. Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds. Nature (New Biol.) 237 (1972) 59
279. Szabo C., Mitchell J.A., Thiemermann C., and Vane J.R. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108 (1993) 786-792
280. Szabo C., Southan G.J., Wood E., Thiemermann C., and Vane J.R. Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: Requirement of a serum factor. Br. J. Pharmacol. 112 (1994) 355-356
281. Tanabe T., Miyata A., Nanayama T., Tone Y., Ihara H., Toh H., Takahashi E.-I., and Ullrich V. Human genes for prostaglandin endoperoxide synthase-2, thromboxane synthase and prostacyclin synthase. Adv. Prostaglandin Thromboxane Leukot. Res. 23 (1995) 133-135
282. 2. J. Exp. Med. 36 (1972) 1329-1343
283. 2 negatively modulates induction of nitric oxide synthase by interleukin-1. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12168-12172
284. Thiemermann C., and Vane J.R. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysacharides in the rat in vivo. Eur. J. Pharmacol. 182 (1991) 591-595
285. M. Thivierge., M. Rola-Pleszczynski., (1994) Upregulation of inducible cyclooxygenase gene expression in rat alveolar macrophages by PAF. Proc. 9th International Conference on prostaglandins and related compounds, Florence, p. 80.
286. Tomlinson A., Appleton I., and Willoughby D.A. Temporal expression and cellular distribution of NADPH diaphorase staining in the chronic granulomatous tissue of the murine croton oil-induced air pouch. Br. J. Pharmacol. 107 (1992) 408P
287. Tomlinson A., Appleton I., Moore A.R., Gilroy D.W., Willis D., Mitchell J.A., and Willoughby D.A. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 113 (1994) 693-698
288. Traub R.J., Solodkin A., and Gebhart G.F. NADPH diaphorase histochemistry provides evidence for a bilateral somatotopically inappropriate response to unilateral hind paw inflammation in the rat. Brain Res. 647 (1994) 113-123
289. Tsai A.-L., Wei C., and Kulmacz R.J. Interaction between nitric oxide and prostaglandin H synthase. Arch. Biochem. Biophys. 313 2 (1994) 367-372
290. Tsunawaki S., Sporn M., Ding A., and Nathan C. Deactivation of macrophages by transforming growth factor β. Nature 334 (1988) 260
291. Urquhart E. Central analgesic activity of nonsteroidal anti-inflammatory drugs in animal and human pain models. Semin. Arthritis Rheum. 23 (1993) 198-205
292. Vallance P., Leone A., Calver A., Collier J., and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339 (1992) 572-575
293. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (London) 231 (1971) 232-235
294. Vane J.R. Prostaglandins as mediators of inflammation. In: Samuelsson B., and Paoletti R. (Eds). "Advances in Prostaglandin and Thromboxane Research" 2 (1976) 791-802
295. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2046-2050
296. Van Epps D. Suppression of human lymphocyte migration by PGE2. Inflammation 5 (1981) 81-87
297. Van der Ouderaa F.J., Buytenhek M., Nugteren D.H., and van Dorp D.A. Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid. Eur. J. Biochem. 109 (1980) 1-8
298. Velo G.P., Dunn C.J., Giroud J.P., Timsit J., and Willoughby D.A. Distribution of prostaglandins in inflammatory exudate. J. Pathol. 111 (1973) 149-157
299. Vodovotz Y., Bogdan C., Park J., Xie Q.W., and Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178 (1993) 605-614
300. Vodovotz Y., Kwon N.S., Pospischil M., Manning J., Park J., and Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with interferon gamma and bacterial lypopolysaccharide. J. Immunol. 152 (1994) 4110-4118
301. Wang L.-H., Hajibeige A., Xu X.-M., Loose-Mitchell D., and Wu K.K. Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem. Biophys. Res. Commun. 406 (1993) 411
302. Warso M.A., and Lands W.E.M. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br. Med. Bull. 39 (1983) 277-280
303. Wasserman M.A., DuCharme D.W., Griffin R.L., DeGraaf G.L., and Robinson F.G. Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog. Prostaglandins 13 (1977) 255-269
304. Webb D.R., and Osheroff P.L. Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 1300-1309
305. Weinberg J.B., Granger D.L., Pisetsky D.S., Seldin M.F., Misukonis M.A., Mason S.N., Pippen A.M., Ruiz P., Wood E.R., and Gilkeson G.S. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerularnephritis and arthritis by orally administered NG-monomethyl-L-arginine. J. Exp. Med. 179 (1994) 651-660
306. Weissman G., Dukor P., and Zurier R.B. Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat. New Biol. 231 (1971) 131-135
307. Weissman G. The actions of NSAIDs. Hosp. Pract. 26 (1991) 60-76
308. Weissman G. Prostaglandins as modulators of inflammation. New Standards Arth. Care 3 (1992) 3-5
309. 2 (prostacyclin) by cultured human and bovine endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 3922-3926
310. Whittle B.J.R. Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins. Eur. J. Pharmacol. 40 (1976) 233-239
311. Whittle B.J.R., Moncada S., and Vane J.R. Comparison of the effects of prostacyclin (PG12), prostaglandin El and D2 on platelet aggregation in different species. Prostaglandins 16 (1978) 373-388
312. Wiertelak E.P., Furness L.E., Watkins L.R., and Maier S.F. Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade. Brain Res. 664 (1994) 9-16
313. Williams T.J., and Peck M.J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature (London) 270 (1977) 530-532
314. Willis A.L. Parrallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion. J. Pharm. Pharmacol. 21 (1969) 216-218
315. Willis A.L. Release of histamine, kinin and prostaglandins during carrageenin-induced inflammation of the rat. In: Mantegazza P., and Horton E.W. (Eds). "Prostaglandins, Peptides and Amines" (1969) 33-38
316. Willis A.L., Smith D.L., and Vigo C. Suppression of principal atherosclerotic mechanisms by prostacyclin and other eicosanoids. Prog. Lipid Res. 25 (1986) 645-666
317. Willis A.L., and Smith D.L. Therapeutic impact of eicosanoids in atherosclerotic disease. Eicosanoids 2 (1989) 69-99
318. Willoughby D.A. Effects of prostaglandins PGF2α and PGE1 on vascular permeability. J. Pathol. 96 (1968) 381-386
319. Wright C.E., Rees D.D., and Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26 (1992) 48-57
320. Wright C.D., Mulsch A., Busse R., and Osswald H. Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Commun. 160 (1989) 813-819
321. Wu K.K., Hatzakis H., Lo S.S., Seong D.C., Sanduja S.K., and Tai H.-H. Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester. J. Biol. Chem. 263 (1988) 19043-19047
322. C. Wu., J.D. Croxtall., and M. Perretti., C.E. Bryant., C. Thiemermann., R.J. Flower., J.R. Vane., (1995) Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc. Natl. Acad. Sci. U.S.A. in press.
323. Xie W., Chapman J.G., Robertson D.L., et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2692-2696
324. X-M. Xu., (1994) Characterization of human prostaglandin H synthase (PGHS)-1 and 2 genes. Proc. 9th International Conference on prostaglandins and related compounds, Florence, p. 30.
325. Xu X.-M., Hajibeige A., Tazawa D., Loose-Mitchell D., Wang L.-H., and Wu K.K. Characterization of human prostaglandin H synthase genes. Adv. Prostaglandin Thromboxane Leukot. Res. 23 (1995) 105-107
326. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurones: Regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386
327. Ziche M., Jones J., and Gullino P.M. Role of prostaglandin El and copper in angiogenesis. J. Natl. Cancer Instit. 69 (1982) 475-482
328. Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., Geppetti P., and Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94 (1994) 2036-2044
329. Zuo J., Lei Z.M., Rao Ch V., Pietrantoni M., and Cook V.D. Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries. J. Clin. Endocrinol. Metab. 79 3 (1994) 894-899